![Jennifer Zibuda](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jennifer Zibuda
Investor Relations Contact chez
SERA PROGNOSTICS, INC.
Profil
Jennifer Zibuda is currently Head-Investor Relations at Sera Prognostics, Inc. since 2025.
Formerly, Ms. Zibuda was Director-Investor Relations & Communications at Prothena Corp.
Plc from 2020 to 2023, Investor Relations Contact at Portola Pharmaceuticals LLC, and Head-Corporate Communications at Alkermes Plc.
Postes actifs de Jennifer Zibuda
| Sociétés | Poste | Début |
|---|---|---|
| SERA PROGNOSTICS, INC. | Investor Relations Contact | 01/07/2025 |
Anciens postes connus de Jennifer Zibuda
| Sociétés | Poste | Fin |
|---|---|---|
| PROTHENA CORPORATION PLC | Investor Relations Contact | 01/01/2023 |
| ALKERMES PLC | Public Communications Contact | 01/06/2018 |
| PORTOLA PHARMACEUTICALS, INC. | Investor Relations Contact | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
26
Relations au 1er degré
4
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Portola Pharmaceuticals LLC
 Portola Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Engages in development and commercialization of novel therapeutics | Health Technology |
Sera Prognostics, Inc.
 Sera Prognostics, Inc. Medical/Nursing ServicesHealth Services Provides personalized diagnostics to predict and manage pregnancy complications | Health Services |
Alkermes Plc
 Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
Prothena Corp. Plc
 Prothena Corp. Plc BiotechnologyHealth Technology Focuses on the discovery and development of novel antibodies | Health Technology |
